[go: up one dir, main page]

DE60120187D1 - Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen - Google Patents

Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Info

Publication number
DE60120187D1
DE60120187D1 DE60120187T DE60120187T DE60120187D1 DE 60120187 D1 DE60120187 D1 DE 60120187D1 DE 60120187 T DE60120187 T DE 60120187T DE 60120187 T DE60120187 T DE 60120187T DE 60120187 D1 DE60120187 D1 DE 60120187D1
Authority
DE
Germany
Prior art keywords
diagnostic
shorten
therapeutic applications
bard1 protein
bard1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120187T
Other languages
English (en)
Other versions
DE60120187T2 (de
Inventor
Fabien Gautier
Jean Harb
Khaled Meflah
Irmgard Irminger-Finger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Irminger-Finger Irmigard Genf/geneva Ch
Original Assignee
Universite de Geneve
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Geneve, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Universite de Geneve
Publication of DE60120187D1 publication Critical patent/DE60120187D1/de
Application granted granted Critical
Publication of DE60120187T2 publication Critical patent/DE60120187T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60120187T 2000-09-01 2001-09-03 Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen Expired - Lifetime DE60120187T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0011207A FR2813606B1 (fr) 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
FR0011207 2000-09-01
PCT/FR2001/002731 WO2002018536A2 (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Publications (2)

Publication Number Publication Date
DE60120187D1 true DE60120187D1 (de) 2006-07-06
DE60120187T2 DE60120187T2 (de) 2007-03-29

Family

ID=8853916

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120187T Expired - Lifetime DE60120187T2 (de) 2000-09-01 2001-09-03 Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Country Status (8)

Country Link
US (2) US7566764B2 (de)
EP (1) EP1313855B1 (de)
JP (1) JP4995399B2 (de)
AT (1) ATE328082T1 (de)
CA (1) CA2421258C (de)
DE (1) DE60120187T2 (de)
FR (1) FR2813606B1 (de)
WO (1) WO2002018536A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155900A1 (de) * 2007-04-02 2010-02-24 Hopitaux Universitaires De Geneve Deletionstragende bard1-isoformen und verwendung davon
WO2012023112A2 (en) 2010-08-17 2012-02-23 Universite De Geneve Bard1 isoforms in lung and colorectal cancer and use thereof
JP6756611B2 (ja) * 2013-10-31 2020-09-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 中和抗体を検出するための競合リガンド結合アッセイ
EP2871480A1 (de) * 2013-11-06 2015-05-13 Bard1Ag SA Lungenkrebsdiagnose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012327A2 (en) * 1996-09-20 1998-03-26 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
US6887468B1 (en) * 1999-04-28 2005-05-03 Board Of Regents, The University Of Texas System Antibody kits for selectively inhibiting VEGF

Also Published As

Publication number Publication date
EP1313855B1 (de) 2006-05-31
ATE328082T1 (de) 2006-06-15
JP4995399B2 (ja) 2012-08-08
US20100016228A1 (en) 2010-01-21
WO2002018536A3 (fr) 2003-01-03
US20040234959A1 (en) 2004-11-25
US7566764B2 (en) 2009-07-28
JP2004518410A (ja) 2004-06-24
FR2813606A1 (fr) 2002-03-08
FR2813606B1 (fr) 2004-04-30
CA2421258A1 (fr) 2002-03-07
WO2002018536A2 (fr) 2002-03-07
EP1313855A2 (de) 2003-05-28
DE60120187T2 (de) 2007-03-29
CA2421258C (fr) 2011-04-19

Similar Documents

Publication Publication Date Title
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
MXPA03010079A (es) Formulaciones de oxicodona de administracion una vez al dia.
MY150237A (en) Cripto blocking antibodies and uses thereof
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
DE60235761D1 (de) Isoform des vegfs
CY1112957T1 (el) Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
GB0100551D0 (en) Protein
DE60027295D1 (de) Sphingosinekinase
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
ATE417618T1 (de) Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren
AUPP472398A0 (en) Protease susceptibility II
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
DE60042487D1 (de) Methode und zusammensetzung zur angiogenese-inhibierung mit antagonisten gegen mmp-9 und beta1-integrine
WO2002077241A3 (en) Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
HUP0402327A2 (hu) Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
PL374550A1 (en) Il-17 like molecules and uses thereof
FR2804127B1 (fr) Gene srn1 implique dans le syndrome nephrotique cortico- resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2003093305A3 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: IRMINGER-FINGER, IRMIGARD, GENF/GENEVA, CH

8364 No opposition during term of opposition